TOSOH BIOSCIENCE-DIAGNOSTICS EMEA

Clinical Interpretation of HbA1c results in patients with haemoglobinopathies

Wednesday Nov. 5^th, 2025, 14:30 CET (1:30 pm GMT) 

Understanding HbA1c results are essential for accurate diabetes diagnosis and monitoring, but what happens when the patient have an haemoglobinopathy?

Join us for an insightful session that explores the analytical and clinical challenges of interpreting HbA1c in patients with haemoglobinopathies. Dr. Stefaan Marivoet will guide participants through the complexities of haemoglobin structure, the formation and measurement of HbA1c, and the impact of variants such as HbS, HbC, HbE, and thalassemias on test accuracy.

Key topics include:

• The genetic and biochemical basis of normal and variant haemoglobins
• How haemoglobinopathies affect HbA1c formation
• Analytical interferences in common HbA1c assay methods
• Clinical implications of altered red blood cell lifespan and turnover
• Strategies for detecting haemoglobin variants and ensuring reliable HbA1c results
  
  

This session is ideal for laboratory professionals, clinicians, and anyone involved in diabetes care who wants to deepen their understanding of HbA1c interpretation in complex patient populations.

Speaker: